Infusystem Holdings vs Neuronetics
Infusystem Holdings and Neuronetics are similar in size: $143m and $149m of revenue in their latest fiscal years. Neuronetics grew faster (99.2% against 6.4%). Infusystem Holdings kept more of each dollar of sales as profit: a net margin of 4.6% against -26.1%. Infusystem Holdings carries less debt relative to equity (34.9% against 312.8%).
| Latest fiscal year | Infusystem HoldingsINFU, 2025 | NeuroneticsSTIM, 2025 |
|---|---|---|
| Revenue | $143m | $149m |
| Revenue growth | 6.4% | 99.2% |
| Net income | $6.6m | −$39.0m |
| Operating margin | 8.3% | -21.1% |
| Net margin | 4.6% | -26.1% |
| Return on equity | 11.5% | -155.7% |
| Free cash flow | $23.8m | −$21.2m |
| Cash | $3.2m | $28.1m |
| Total debt | $20.0m | $70.0m |
| Debt to equity | 34.9% | 312.8% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | $9.9m | — |
| Employees | 473 | 658 |
| Market value | $255m | $171m |
| Price vs our value range | Within our value range | — |
| Moat score | 64 (Moderate) | 26 (Weak) |
| Insider trades, 12 months | 5 buys, 0 sales | 15 buys, 11 sales |